# OnCo record compete (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/compete/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "compete", "NCT03049189" ;
  schema:name "COMPETE"@en ;
  schema:description "The first head-to-head trial of a radioligand against a targeted pill in neuroendocrine tumours; the radioligand won on progression-free survival."@en ;
  schema:url <https://onco.cc/trials/compete/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03049189>, <https://www.cancernetwork.com/view/itm-11-demonstrates-superior-pfs-vs-everolimus-in-sstr-gep-nets> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2017-02-02" ;
  onco:related <https://onco.cc/collections/src-cancer-network/> ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/pancreatic-net/>, <https://onco.cc/cancers/small-intestinal-net/> ;
  onco:technologies <https://onco.cc/technologies/prrt/> ;
  onco:targets <https://onco.cc/targets/sstr2/> ;
  onco:drugs <https://onco.cc/drugs/itm-11/>, <https://onco.cc/drugs/everolimus/> ;
  onco:companies <https://onco.cc/companies/itm/> ;
  onco:people <https://onco.cc/people/jonathan-strosberg/> .